HRMY (harmonybiosciences.com) Yakuniy foyda

HRMY (Harmony Biosciences Holdings, Inc.) - kompaniyaning tovar belgisi

Harmony Biosciences (HRMY) narkolepsiya terapiyasi bo'yicha monopol maqomini ishga solgan holda va ishlab chiqarishni autsorsing qilish xarajatlarini minimallashtirgan holda foydani oshirmoqda. Barqaror pul oqimlari blokbaster patent va bemorlarning doimiy talabi bilan ta'minlangan bo'lib, hozirgi vaqtda foyda 0.18 miqdorini tashkil etmoqda. Ushbu narxlar grafigi aktivning narx harakatini aniq ko'rsatadi. O'sish istiqbollari esa uning noyob uyqu buzilishlari davolash vositalari uchun tibbiy ko'rsatmalarning kengayishida jamlangan.

Harmony Corp (HRMY) Kompaniyaning sof foydasi: 04.07.2022 - 31.10.2026 davri uchun

Harmony Biosciences Holdings, Inc. (HRMY) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Harmony Corp|HRMY - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor qiymati Harmony Corp|HRMY - Korxona qiymati
- biznesning balans baholash tafsilotlari:
Bitta aksiya hisobiga balans qiymati Harmony Biosciences|HRMY - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati harmonybiosciences.com|HRMY - Kompaniyaning jami aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning xususiy kapitalga nisbati Harmony Biosciences|HRMY - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Harmony Biosciences Inc|HRMY - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Harmony Corp|HRMY - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli qarz Harmony Biosciences|Oraliq qoplash koeffitsiyenti harmonybiosciences.com
- foyda va bozor multiplikatorlari tafsilotlari:
HRMY - Sof foyda
Kompaniyaning asosiy tahlili:Harmony Corp
Harmony Biosciences asosiy tovari

Ushbu ko'rsatkichning dinamikasi bevosita Harmony Biosciences (HRMY) kompaniyasining operatsion samaradorligiga bog'liq. Mazkur indikator haqiqiy o'sish omillarini aniqlash uchun bozor shovqinlaridan tozalangan kunlik sof foydani aks ettiradi. Kam uchraydigan uyqu buzilishlari uchun dori vositalarining barqaror savdosi ushbu hisob-kitob modelining chidamliligini tasdiqlaydi. Harmony Biosciences (HRMY) moliyaviy natijalarini tahlil qilish fundamental muvaffaqiyatlar qanday qilib kapitalga aylantirilishini baholash imkonini beradi. Biroq, tarixiy trayektoriya kelajakdagi xavflarni istisno qilmaydi.

Muhim raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Sof foyda|RGC: Yakuniy foyda|Sof foyda AXSM|Sof foyda ACADIA Pharma (ACAD)|Kompaniyaning sof foydasi Xenon Pharmaceuticals Inc XENE|Yakuniy foyda VKTX|SUPN - Kompaniyaning sof foydasi|catalystpharma.com (CPRX) - Sof daromad|Denali Therapeutics Inc. (DNLI) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Biohaven Ltd (BHVN)|Kompaniyaning sof foydasi Amylyx|Kompaniya foydasi TRVI (Trevi Corp)|Sof daromad PRAX (Praxis Precision Medicines)|AVXL - Kompaniyaning sof daromadi|CeriBell - Sof daromad|Yakuniy foyda PRTA|Alector Therapeutics - Sof foyda|ANNX: Kompaniyaning sof foydasi|OMER: Sof foyda|NGNE - Sof moliyaviy natija|Kompaniyaning sof foydasi AC Immune SA|Kompaniyaning sof daromadi Voyager Therapeutics Inc VYGR|Kompaniyaning sof foydasi Neumora Therapeutics Inc (NMRA)|Sof moliyaviy natija Scilex Holding Company, Inc.|Sof foyda TVGN (Tevogen Bio Holdings)|ACOG - Sof daromad|Cognition Therapeutics - Sof foyda|Sof moliyaviy natija Inhibikase Therapeutics Inc IKT|SAVA: Sof foyda|Kompaniyaning sof daromadi Assertio (ASRT)|Kompaniyaning sof foydasi Coya Therapeutics Inc|Kompaniya foydasi VTGN (VistaGen Therapeutics Inc)|Sof foyda OVID|Sof daromad Acumen Pharmaceuticals Inc. ABOS|Sof foyda CRVO (CervoMed Inc)|Alterity Therapeutics Ltd. (ATHE) - Kompaniyaning sof daromadi|CLNN - Kompaniyaning sof foydasi|Sof moliyaviy natija PepGen Inc. PEPG|JUNS: Sof foyda|Relmada Therapeutics Inc - Yakuniy foyda|Kompaniyaning sof foydasi Annovis Bio Corp|GRCE: Yakuniy foyda|Kompaniyaning sof foydasi Firefly Neuroscience, Inc (AIFF)|Sof daromad anewmeds.com KLTO|NeuroSense Therapeutics Ltd. - Sof daromad|Reviva Pharmaceuticals Holdings Inc. (RVPH) - Kompaniyaning sof daromadi|MTVA - Kompaniyaning sof foydasi|NRXS (NeurAxis Inc) - Kompaniya foydasi|HSDT: Sof foyda|Kompaniyaning sof daromadi Passage Bio (PASG)|Sof daromad NEUP|Sof foyda Minerva Neurosciences Inc|Kompaniyaning sof foydasi Athira (ATHA)|ADXN (Addex) - Yakuniy foyda|Kompaniyaning sof foydasi Alzamend Neuro ALZN|Cyclerion Therapeutics Inc. (CYCN) - Kompaniyaning sof daromadi|Protagenic - Sof foyda|Yakuniy foyda KTTA (Pasithea Therapeutics)|CRGT: Sof foyda|Avenue Therapeutics Inc (ATXI) - Sof foyda|Kompaniyaning sof foydasi Brainstorm Cell|CARA: Yakuniy foyda|Kompaniyaning sof foydasi Chromocell Therapeutics Corp. (CHRO)|Sof daromad eliemtx.com ELYM|Kompaniyaning sof foydasi Intra-Cellular Therapies, Inc. ITCI|Longboard (LBPH) - Kompaniyaning sof daromadi|MRNS - Kompaniyaning sof foydasi|NKGN (nkgenbiotech.com) - Kompaniya foydasi|NRBO (NeuroBo Pharmaceuticals, Inc.) - Sof daromad|Kompaniyaning sof daromadi Sage Therapeutics Inc. (SAGE)|Sof daromad SNPX|TRVN: Yakuniy foyda|Sof foyda VIGL|Kompaniyaning sof foydasi WENA (Anew Medical Inc.)|Sof foyda CERE (Cerevel Therapeutics, Inc.)